4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0000902664-19-002915
Director acquired 17,332,191 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
GOEL DAVID E. · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-07-01 | Conversion : show line 1 in the form | +200,000 | 200,000 | I |
| 2019-07-01 | Conversion : show line 2 in the form | +5,893,716 | 6,093,716 | I |
| 2019-07-01 | Conversion : show line 3 in the form | +11,154,116 | 17,247,832 | I |
| 2019-07-01 | Conversion : show line 4 in the form | +84,359 | 17,332,191 | I |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-07-01 | Conversion : show line 5 in the form Series A Convertible Preferred Stock | −200,000 | 0 | I |
| 2019-07-01 | Conversion : show line 6 in the form Series E-1 Convertible Preferred Stock | −5,893,716 | 0 | I |
| 2019-07-01 | Conversion : show line 7 in the form Series F Convertible Preferred Stock | −11,154,116 | 0 | I |
| 2019-07-01 | Conversion : show line 8 in the form Series F-1 Convertible Preferred Stock | −84,359 | 0 | I |
Loading xslF345X03/ownership.xml…